Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method and applications of polyasparagine-RGDF-antitumor drug compound

An anti-tumor drug, polyaspartic acid technology, which is applied in the field of preparation and application of polyaspartic acid-RGDF-anti-tumor drug complexes, and can solve problems such as unsolved main problems

Active Publication Date: 2016-08-24
北京恒润泰生医药科技有限公司
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the measures and strategies seen in the literature have achieved some success, major issues remain unresolved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and applications of polyasparagine-RGDF-antitumor drug compound
  • Preparation method and applications of polyasparagine-RGDF-antitumor drug compound
  • Preparation method and applications of polyasparagine-RGDF-antitumor drug compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1 Mesoscopic simulation of the three-dimensional morphology of polyaspartyl-RGDF at neutral and pH5.4

[0020] Construction of dimers of α,β-dl-asparagine-Arg-Gly-Asp-Phe was energy optimized with Discovery Studio 4.0. Input the energy-optimized dimer into Materials Studio 7.0 to construct polyaspartate-RGDF with a chain length of 119 aspartic acid residues and 118 RGDF tetrapeptides with a molecular weight of 69753. N-terminal NH 2 The H atoms (also known as head H atoms) are labeled H1 and H2, and the C-terminal CO 2 The oxygen atoms (also known as tail oxygen atoms) of H are labeled O1 and O2.

[0021] Correspondingly, when the dimer of α, β-dl-asparagine-Arg-Gly-Asp-Phe forms a tetramer, there are H1 / O1, H2 / O1, H2 / O1 when the head H atom and the tail oxygen atom form a peptide bond, Approximate pathways of four collocations of H1 / O2 and H2 / O2. Their energies were minimized using Material Studio 7.0's COMPASS force field until the energies stabilized. Th...

Embodiment 2

[0023] Embodiment 2 prepares polyasparagine-RGDF

[0024] The chain length is 119 aspartic acid residues, 118 RGDF tetrapeptides are linked, and the preparation of polyasparagine-RGDF with a molecular weight of 69753 is carried out completely according to the disclosed method.

[0025] 1) Preparation of Boc-Arg(Tos)-Gly-OBzl

[0026]Dissolve 4.986g (11.64mmol) of Boc-Arg (Tos), 1.310g (9.7mmol) of HOBt in 30mL of anhydrous THF, add 2.398g (11.64mmol) of DCC in anhydrous THF to the resulting solution, and stir in an ice bath 20min, the reaction solution I was obtained. A solution of 3.273 g (9.7 mmol) Tos·Gly-OBzl and 30 mL of anhydrous THF was adjusted to pH 9 with NMM to obtain reaction solution II. The reaction solution II was added to the reaction solution I, and reacted at room temperature for 12 hours. TLC (acetone:petroleum ether=2:1) ​​showed that the reaction was complete. The DCU precipitate was removed by filtration, the filtrate was concentrated under reduced pr...

Embodiment 3

[0044] Example 3 Determination of the nanostructure of polyaspartic acid-RGDF by transmission electron microscopy

[0045] Polyaspartyl-RGDF was formulated in ultrapure water to a concentration of 10 -6 nM solution, and then drop this solution on the copper grid, and observe the nano-morphology under the JEM-1230 transmission electron microscope after the solvent is evaporated. The measurement shows that the polyaspartyl-RGDF forms a diameter of 38-200nm, and most of the nanospheres have a diameter of 38-180nm. The surface of the nanospheres is covered with pores with a diameter of 4-11 nm (see image 3 , A-D). It is easy to imagine that when hyacinth-like nanorod-like polyaspartyl-RGDF molecules distributed with pores and circular channels are assembled into nanospheres, the surface of the nanospheres will of course be covered with pores.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a polyasparagine-RGDF compound represented by the formula and a three dimensional morphology of the compound under a neutral condition or a condition of pH 5.4, a polyasparagine-RGDF-antitumor drug compound, wherein the mole ratio of polyasparagine-RGDF to antitumor drug is 1:120, and a preparation method of the polyasparagine-RGDF-antitumor drug compound. The polyasparagine-RGDF-antitumor drug compound can inhibit tumor cells, especially the proliferation activity of tumor cells that are resistant to drugs. Moreover, the polyasparagine-RGDF-antitumor drug compound can inhibit the growth of S180 sarcoma. The invention also discloses the clinical application prospect of the polyasparagine-RGDF-antitumor drug compound.

Description

technical field [0001] The present invention relates to the three-dimensional form of the compound of the following formula known as polyasparagine-RGDF under the condition of neutrality and pH 5.4, and the molar ratio of polyaspartate-RGDF and antitumor drug is 1 / 120 complex ( Polyaspartyl-RGDF-antitumor drug complex for short), relates to the preparation method of this type of polyasparagine-RGDF-antineoplastic drug complex, relates to the inhibition of this type of polyaspartyl-RGDF-antitumor drug complex The activity of tumor cells, especially inhibiting the proliferation of tumor drug-resistant cells, is further related to the activity of this kind of polyaspartate-RGDF-antitumor drug complex to inhibit the growth of S180 sarcoma. Therefore, the present invention relates to the clinical application prospect of the polyasparagine-RGDF-antitumor drug complex. The invention belongs to the field of biomedicine. [0002] Background technique [0003] Malignant tumors se...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/48A61K9/14A61P35/00C08G73/10A61K31/704
Inventor 彭师奇赵明
Owner 北京恒润泰生医药科技有限公司